Reinders JH - Search Results

1

No evidence for binding of clozapine, olanzapine and/or haloperidol to selected receptors involved in body weight regulation.

Theisen FM, Haberhausen M, Firnges MA, Gregory P, Reinders JH, Remschmidt H, Hebebrand J, Antel J. Theisen FM, et al. Among authors: reinders jh. Pharmacogenomics J. 2007 Aug;7(4):275-81. doi: 10.1038/sj.tpj.6500418. Epub 2006 Sep 19. Pharmacogenomics J. 2007. PMID: 16983399

2

Clozapine-related myocarditis and cardiomyopathy in an Australian metropolitan psychiatric service.

Reinders J, Parsonage W, Lange D, Potter JM, Plever S. Reinders J, et al. Aust N Z J Psychiatry. 2004 Nov-Dec;38(11-12):915-22. doi: 10.1080/j.1440-1614.2004.01481.x. Aust N Z J Psychiatry. 2004. PMID: 15555025

3

Electroconvulsive therapy, personal protective equipment and aerosol generating procedures: a review to guide practice during Coronavirus Disease 2019 (COVID-19) pandemic.

Purushothaman S, Fung D, Reinders J, Garrett-Walcott S, Buda M, Moudgil V, Emmerson B. Purushothaman S, et al. Australas Psychiatry. 2020 Dec;28(6):632-635. doi: 10.1177/1039856220953699. Epub 2020 Sep 10. Australas Psychiatry. 2020. PMID: 32910692 Review.

4

Potent dihydroquinolinone dopamine D2 partial agonist/serotonin reuptake inhibitors for the treatment of schizophrenia.

Yan Y, Zhou P, Rotella DP, Feenstra R, Kruse CG, Reinders JH, van der Neut M, Lai M, Zhang J, Kowal DM, Carrick T, Marquis KL, Pausch MH, Robichaud AJ. Yan Y, et al. Among authors: reinders jh. Bioorg Med Chem Lett. 2010 May 1;20(9):2983-6. doi: 10.1016/j.bmcl.2010.02.105. Epub 2010 Mar 3. Bioorg Med Chem Lett. 2010. PMID: 20347298

5

Development and application of an LC-MS/MS method for measuring the effect of (partial) agonists on cAMP accumulation in vitro.

Goutier W, Spaans PA, van der Neut MA, McCreary AC, Reinders JH. Goutier W, et al. Among authors: reinders jh. J Neurosci Methods. 2010 Apr 30;188(1):24-31. doi: 10.1016/j.jneumeth.2010.01.027. Epub 2010 Feb 1. J Neurosci Methods. 2010. PMID: 20122962

6

Tetrahydrocarbazole-based serotonin reuptake inhibitor/dopamine D2 partial agonists for the potential treatment of schizophrenia.

Rotella DP, McFarlane GR, Greenfield A, Grosanu C, Robichaud AJ, Denny RA, Feenstra RW, Núñez-García S, Reinders JH, Neut Mv, McCreary A, Kruse CG, Sullivan K, Pruthi F, Lai M, Zhang J, Kowal DM, Carrick T, Grauer SM, Navarra RL, Graf R, Brennan J, Marquis KL, Pausch MH. Rotella DP, et al. Among authors: reinders jh. Bioorg Med Chem Lett. 2009 Oct 1;19(19):5552-5. doi: 10.1016/j.bmcl.2009.08.050. Epub 2009 Aug 15. Bioorg Med Chem Lett. 2009. PMID: 19720528

7

7-Azaindole derivatives as potential partial nicotinic agonists.

Stoit AR, den Hartog AP, Mons H, van Schaik S, Barkhuijsen N, Stroomer C, Coolen HK, Reinders JH, Adolfs TJ, van der Neut M, Keizer H, Kruse CG. Stoit AR, et al. Among authors: reinders jh. Bioorg Med Chem Lett. 2008 Jan 1;18(1):188-93. doi: 10.1016/j.bmcl.2007.10.101. Epub 2007 Nov 1. Bioorg Med Chem Lett. 2008. PMID: 18006307

8

Principal component analysis differentiates the receptor binding profiles of three antipsychotic drug candidates from current antipsychotic drugs.

Lange JH, Reinders JH, Tolboom JT, Glennon JC, Coolen HK, Kruse CG. Lange JH, et al. Among authors: reinders jh. J Med Chem. 2007 Oct 18;50(21):5103-8. doi: 10.1021/jm070516u. Epub 2007 Sep 19. J Med Chem. 2007. PMID: 17880057

9

In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist.

Glennon JC, Van Scharrenburg G, Ronken E, Hesselink MB, Reinders JH, Van Der Neut M, Long SK, Feenstra RW, McCreary AC. Glennon JC, et al. Among authors: reinders jh. Synapse. 2006 Dec 15;60(8):599-608. doi: 10.1002/syn.20330. Synapse. 2006. PMID: 17001660

10

SLV313 (1-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-4- [5-(4-fluoro-phenyl)-pyridin-3-ylmethyl]-piperazine monohydrochloride): a novel dopamine D2 receptor antagonist and 5-HT1A receptor agonist potential antipsychotic drug.

McCreary AC, Glennon JC, Ashby CR Jr, Meltzer HY, Li Z, Reinders JH, Hesselink MB, Long SK, Herremans AH, van Stuivenberg H, Feenstra RW, Kruse CG. McCreary AC, et al. Among authors: reinders jh. Neuropsychopharmacology. 2007 Jan;32(1):78-94. doi: 10.1038/sj.npp.1301098. Epub 2006 May 17. Neuropsychopharmacology. 2007. PMID: 16710314

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

28 results

Search Page